MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

12 Aug 2024 Evaluate
The revenue slipped marginally during the June 2024 quarter. A decline of about Rs. 170.45 millions was observed as compared to Rs. 176.57 millions during the corresponding quarter last year.The Profit  for the quarter ended June 2024 of  Rs. 1.67  millions  grew by 51.82% from Rs. 1.10 millions.Operating Profit saw a handsome growth to 4.51 millions from 3.56 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 170.45 176.57 -3.47 170.45 176.57 -3.47 672.81 653.49 2.96
Other Income 0.45 0.01 4400.00 0.45 0.01 4400.00 4.21 3.27 28.75
PBIDT 4.51 3.56 26.69 4.51 3.56 26.69 27.18 28.16 -3.48
Interest 0.21 0.23 -8.70 0.21 0.23 -8.70 0.63 0.80 -21.25
PBDT 4.30 3.33 29.13 4.30 3.33 29.13 26.55 27.36 -2.96
Depreciation 1.59 1.22 30.33 1.59 1.22 30.33 5.83 5.17 12.77
PBT 2.71 2.11 28.44 2.71 2.11 28.44 20.72 22.19 -6.62
TAX 1.04 1.01 2.97 1.04 1.01 2.97 6.12 6.96 -12.07
Deferred Tax 0.29 0.44 -34.09 0.29 0.44 -34.09 0.25 0.34 -26.47
PAT 1.67 1.10 51.82 1.67 1.10 51.82 14.60 15.23 -4.14
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 2.65 2.02 31.23 2.65 2.02 31.23 4.04 4.31 -6.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..